Medical Subject Headings

Last uploaded: March 22, 2026

Id	http://purl.bioontology.org/ontology/MESH/C511895 http://purl.bioontology.org/ontology/MESH/C511895
Preferred Name	ertumaxomab
Type	http://www.w3.org/2002/07/owl#Class

prefLabel	ertumaxomab
II	D018033
Scope Statement	trifunctional anti-HER2 x anti-CD3 antibody for treatment of metastatic breast cancer; in Phase I trial (5/2006)
type	http://www.w3.org/2002/07/owl#Class
tui	T116 T129 T121
HM	D000911
SC	1
TERMUI	T678269
TH	INN (19XX) NLM (2006)
SRC	Clin Cancer Res 2006 May 15;12(10):3085-91
MMR	20191031
notation	C511895
Semantic type UMLS property	http://purl.bioontology.org/ontology/STY/T129 http://purl.bioontology.org/ontology/STY/T121 http://purl.bioontology.org/ontology/STY/T116
cui	C1723386
MeSH Frequency	9
DSC	20060720
Inverse of RB	L5L45YGP1O
Mapped to	http://purl.bioontology.org/ontology/MESH/D000911
MDA	20060720

Delete	Subject	Author	Type	Created
No notes to display